Imugene Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Imugene Limited with three other
companies in this sector in AUSTRALIA :
Medlab Clinical Ltd
sales of 5.37 million Australian Dollars [US$4.14 million]
of which 67%
was Pharmaceutical Research),
Paradigm Biopharmaceuticals Ltd
(4.70 million Australian Dollars [US$3.62 million]
(3.48 million Australian Dollars [US$2.68 million]
of which 100%
was Drug Development).
Sales were up sharply during the second
quarter of 2021 versus the previous year's second quarter.
During the second
quarter of 2021, sales at Imugene Limited totalled
an increase of 73.1%
from the A$2.37 million in sales at the company during the second quarter of 2020.
Imugene Limited reported sales of A$4.21 million (US$3.25 million)
June of 2020.
decrease of 7.3%
versus 2019, when the company's sales were A$4.54 million.